Issue 2/2012

Time trends in cervical cancer epidemiology in the Slovak Republic: reflection on the non-implementation of screening with international comparisons (121 — 128)

M. ONDRUSOVA, P. ZUBOR, D. ONDRUS

DOI: 10.4149/neo_2012_016

POSTOPERATIVE RADIOCHEMOTHERAPY WITH WEEKLY CISPLATIN IN PATIENTS WITH HEAD AND NECK CANCER SINGLE-INSTITUTION OUTCOME ANALYSIS (129 — 136)

M. PALA, K. ODRAZKA, P. HOLECKOVA, P. VITEK, J. KUBES, T. PODLESAK, J. KLOZAR, L. PETRUZELKA

DOI: 10.4149/neo_2012_017

Immunohistochemical analysis of the mTOR pathway in intrahepatic cholangiocarcinoma (137 — 141)

Z. WANG, T. ZHENG, Q. WU, J. WANG, C. WU, J. WANG

DOI: 10.4149/neo_2012_018

Effects of pantoprazole as a HIF-1α inhibitor on human gastric adenocarcinoma sgc-7901 cells (142 — 149)

Y. SHEN, Y. WU, M. CHEN, W. SHEN, S. HUANG, L. ZHANG, X. ZOU

DOI: 10.4149/neo_2012_019

Diagnostic performance of Des-γ-carboxy prothrombin (DCP) for Hepatocellular carcinoma: A Bivariate Meta-analysis (150 — 159)

P. GAO, M. LI, Q. B. TIAN, DIAN-WU LIU

DOI: 10.4149/neo_2012_020

Lung Adenocarcinoma and Squamous Cell Carcinoma in association with Genetic Polymorphisms of GSTs in Slovak Population (160 — 167)

A. DZIAN, E. HALASOVA, T. MATAKOVA, E. KAVCOVA, M. SMOLAR, D. DOBROTA, J. HAMZIK, D. MISTUNA

DOI: 10.4149/neo_2012_021

Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia (168 — 174)

H. CECHOVA, P. LASSUTHOVA, L. NOVAKOVA, M. BELICKOVA, R. STEMBERKOVA, J. JENCIK, M. STANKOVA, P. HRABAKOVA, K. PEGOVA, H. ZIZKOVA, J. CERMAK

DOI: 10.4149/neo_2012_022

The significance of portal vein embolization in the treatment of colorectal liver metastases (175 — 182)

P. ZBORIL, K. VYSLOUZIL, I. KLEMENTA, P. SKALICKY, K. VOMACKOVA, M. CERNA, K. CWIERTKA

DOI: 10.4149/neo_2012_023

Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation (183 — 190)

S. SIVGIN, S. BALDANE, L. KAYNAR, F. KURNAZ, C. PALA, H. SIVGIN, A. OZTURK, M. CETIN, A. UNAL, B. ESER

DOI: 10.4149/neo_2012_024

Evaluation ofalpha-methylacyl-CoA racemase, metallothionein and prostate specific antigen as prostate cancer prognostic markers (191 — 201)

J. GUMULEC, M. MASARIK, S. KRIZKOVA, M. HLAVNA, P. BABULA, R. HRABEC, A. ROVNY, M. MASARIKOVA, J. SOCHOR, V. ADAM, T. ECKSCHLAGER, R. KIZEK

DOI: 10.4149/neo_2012_025

Fiber-optic bronchoscope and detection of lung cancer: A five year study (201 — 206)

L. GAO, T. ASMITANAND, H. REN, F. WU, Y. ZHANG, X. LI, L. DI, Z. SONG, T. YANG, T. CHEN, M. MERRILEES, L. WU, M. CHEN

DOI: 10.4149/neo_2012_026

Overexpression of potassium channel ether à go-go in human osteosarcoma (207 — 215)

J. WU, X. WU, K. LIAN, B. LIN, L. GUO, Z. DING

DOI: 10.4149/neo_2012_027

Cigarette smoking extract causes hypermethylation and inactivation of WWOX gene in T-24 human bladder cancer cells (216 — 223)

W. YANG, S. CUI, J. MA, Q. LU, C. KONG, T. LIU, Z. SUN

DOI: 10.4149/neo_2012_028

Immunohistochemical analysis of gastrin-releasing peptide receptor (GRPR) and possible regulation by estrogen receptor βcx in human prostate carcinoma (224 — 232)

S. NAGASAKI, Y. NAKAMURA, T. MAEKAWA, J. AKAHIRA, Y. MIKI, T. SUZUKI, S. ISHIDOYA, Y. ARAI, H. SASANO

DOI: 10.4149/neo_2012_029

Docetaxel and Cisplatin Plus Fluorouracil Compared With Modified Docetaxel, Cisplatin, and 5-Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Retrospective Analysis of Single Institution (233 — 236)

A. INAL, M. A. KAPLAN, M. KUCUKONER, A. ISIKDOGAN

DOI: 10.4149/neo_2012_030